Regeneron says antibody cocktail reduces risk of contracting Covid by 80% for at least 8 MONTHS

Regeneron says its antibody cocktail REGEN-COV reduces the risk of contracting COVID-19 by 81.6% two to eight months after it is administered. During this period, seven people in the treatment group developed Covid compared to 38 in the placebo group. None of the people given the cocktail were hospitalized with the virus compared to five who received a placebo. The drug was authorized last year as a treatment for COVID-19 but has since been expanded so it can be used as a prophylactic